Arcellx is a clinical-stage biotechnology company that develops cell therapies for cancer and other serious diseases. Its programs focus on engineered immune cell platforms and related biopharmaceutical research and development.
No data available
Are you interested in the impact of this company or this ETF?
It seems we haven't collected any data here yet. Just let us know and we will try to find data as soon as possible. Thank you for your feedback!